Abstract

Photodynamic Therapy dosimetry is an unresolved issue for treatment effectiveness, particularly when using nanoparticles. In this work the treatment and fluorescence-based diagnosis is analyzed when applied to infiltrative Basal Cell Carcinoma.

© 2016 Optical Society of America

PDF Article
More Like This
Study for the clinical implantation of Photodynamic Therapy applied to Squamous Cell Carcinoma

Irene Salas-García, Félix Fanjul-Vélez, Mihail Zverev, and José Luis Arce-Diego
FTu2F.6 Frontiers in Optics (FiO) 2014

Predictive model for Photodynamic Therapy with gold nanoparticles as vehicle for the photosensitizer delivery

I. Salas-García, F. Fanjul-Vélez, N. Ortega-Quijano, and J. L. Arce-Diego
88030N European Conference on Biomedical Optics (ECBO) 2013

Laser-based diagnostics in connection with a phase III clinical study of δ-aminolevulinic acid (ALA) photodynamic therapy of basal cell carcinomas

Claes af Klinteberg, Annika M.K. Enejder, Stefan Andersson-Engels, Sune Svanberg, Ingrid Wang, and Katarina Svanberg
JMA5 Biomedical Topical Meeting (BIO) 1999

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access Optica Member Subscription

Poster Presentation

Media 1: PDF (1333 KB)